Short Interest in Bioxytran, Inc. (OTCMKTS:BIXT) Rises By 92.9%

Bioxytran, Inc. (OTCMKTS:BIXT) saw a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 54,400 shares, an increase of 92.9% from the February 29th total of 28,200 shares. Based on an average daily trading volume, of 179,700 shares, the days-to-cover ratio is currently 0.3 days.

Bioxytran Stock Performance

BIXT remained flat at $0.11 during trading on Friday. 48,608 shares of the company’s stock were exchanged, compared to its average volume of 72,376. The company’s 50 day moving average price is $0.12 and its two-hundred day moving average price is $0.14. The stock has a market capitalization of $17.52 million, a P/E ratio of -2.65 and a beta of -0.75. Bioxytran has a 1 year low of $0.07 and a 1 year high of $0.54.

Bioxytran Company Profile

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.